Burcon NutraScience Valuation

BU Stock  CAD 1.94  0.04  2.02%   
Based on Macroaxis valuation methodology, the firm appears to be overvalued. Burcon NutraScience shows a prevailing Real Value of C$1.64 per share. The current price of the firm is C$1.94. Our model approximates the value of Burcon NutraScience from analyzing the firm fundamentals such as Shares Outstanding of 12.69 M, operating margin of (8.13) %, and Return On Equity of -12.46 as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Burcon NutraScience's valuation include:
Price Book
5.9696
Enterprise Value
25.1 M
Enterprise Value Ebitda
(2.57)
Price Sales
30.6266
Forward PE
454.5455
Overvalued
Today
1.94
Please note that Burcon NutraScience's price fluctuation is dangerous at this time. Calculation of the real value of Burcon NutraScience is based on 3 months time horizon. Increasing Burcon NutraScience's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Burcon NutraScience is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Burcon Stock. However, Burcon NutraScience's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  1.94 Real  1.64 Hype  1.94
The intrinsic value of Burcon NutraScience's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Burcon NutraScience's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
1.64
Real Value
6.19
Upside
Estimating the potential upside or downside of Burcon NutraScience helps investors to forecast how Burcon stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Burcon NutraScience more accurately as focusing exclusively on Burcon NutraScience's fundamentals will not take into account other important factors:
Earnings
Estimates
LowProjectedHigh
0.00-0.040.00
Details
Hype
Prediction
LowEstimatedHigh
0.101.946.49
Details
Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Burcon NutraScience's intrinsic value based on its ongoing forecasts of Burcon NutraScience's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Burcon NutraScience's closest peers.

Burcon NutraScience Cash

4.92 Million

Burcon NutraScience Total Value Analysis

Burcon NutraScience is currently anticipated to have takeover price of 25.12 M with market capitalization of 24.61 M, debt of 22.4 M, and cash on hands of 1.46 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Burcon NutraScience fundamentals before making investing decisions based on enterprise value of the company
  Takeover PriceMarket CapDebt ObligationsCash
25.12 M
24.61 M
22.4 M
1.46 M

Burcon NutraScience Investor Information

About 30.0% of the company shares are held by company insiders. The company recorded a loss per share of 2.52. Burcon NutraScience had not issued any dividends in recent years. The entity had 1:20 split on the 11th of June 2025. Based on the measurements of operating efficiency obtained from Burcon NutraScience's historical financial statements, Burcon NutraScience is not in a good financial situation at this time. It has a very high probability of going through financial hardship in March.

Burcon NutraScience Asset Utilization

The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Burcon NutraScience has an asset utilization ratio of 1.24 percent. This suggests that the Company is making C$0.0124 for each dollar of assets. An increasing asset utilization means that Burcon NutraScience is more efficient with each dollar of assets it utilizes for everyday operations.
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes

Burcon NutraScience Profitability Analysis

Based on the measurements of profitability obtained from Burcon NutraScience's financial statements, Burcon NutraScience may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in March. Profitability indicators assess Burcon NutraScience's ability to earn profits and add value for shareholders.
 
Net Loss  
First Reported
1999-06-30
Previous Quarter
-3.5 M
Current Value
-3.6 M
Quarterly Volatility
1.7 M
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
As of the 1st of February 2026, Gross Profit is likely to drop to about (1.1 M). In addition to that, Pretax Profit Margin is likely to drop to -20.48
For Burcon NutraScience profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Burcon NutraScience to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Burcon NutraScience utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Burcon NutraScience's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Burcon NutraScience over time as well as its relative position and ranking within its peers.

Burcon NutraScience Earnings per Share Projection vs Actual

By analyzing Burcon NutraScience's earnings estimates, investors can diagnose different trends across Burcon NutraScience's analyst sentiment over time as well as compare current EPS estimates against different timeframes. Please be aware that the consensus of earnings estimates for Burcon NutraScience is based on EPS before non-recurring items and includes expenses related to employee stock options.
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Burcon NutraScience is projected to generate -0.04 in earnings per share on the 31st of December 2025. Burcon NutraScience earnings estimates show analyst consensus about projected Burcon NutraScience EPS (Earning Per Share). It derives the highest and the lowest estimates based on Burcon NutraScience's historical volatility. Many public companies, such as Burcon NutraScience, manage the perception of their earnings on a regular basis to make sure that analyst estimates are accurate. Future earnings calculations are also an essential input when attempting to value a firm.

Burcon NutraScience Ownership Allocation

The market capitalization of Burcon NutraScience is C$24.61 Million. Burcon NutraScience retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Note, that even with negative profits, if the true value of the firm is larger than the current market value, you may still be able to generate positive returns on investment in this company.

Burcon NutraScience Profitability Analysis

The company reported the revenue of 381.4 K. Net Loss for the year was (8.26 M) with loss before overhead, payroll, taxes, and interest of (3.96 M).

About Burcon NutraScience Valuation

We use absolute and relative valuation methodologies to arrive at the intrinsic value of Burcon NutraScience. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Burcon NutraScience based exclusively on its fundamental and basic technical indicators. By analyzing Burcon NutraScience's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Burcon NutraScience's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Burcon NutraScience. We calculate exposure to Burcon NutraScience's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Burcon NutraScience's related companies.
Last ReportedProjected for Next Year
Gross Profit-1 M-1.1 M
Pretax Profit Margin(19.50)(20.48)
Operating Profit Margin(18.17)(19.08)
Net Loss(19.50)(20.48)
Gross Profit Margin(2.05)(2.16)

Other Information on Investing in Burcon Stock

Burcon NutraScience financial ratios help investors to determine whether Burcon Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Burcon with respect to the benefits of owning Burcon NutraScience security.